13F-HR/A filed by Eiger Wealth Management, LLC
Eiger Wealth Management, LLC filed this 13F-HR/A for the quarter ended 2026-03-31, accepted by EDGAR 2026-11-04 20:37:07 UTC, with 14 holding rows worth $3,043,591.
- Accession
- 0002161353-26-000007
- Filer
- CIK 2161353
- Filed
- 2026-11-04
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q1 2026
A combination report, amendment of type restatement, 14 entries on the cover page, a total value of $3,043,591 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,043,591 with VALUE read as dollars as filed, 13F file number 028-27256. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerZACKS INVESTMENT MANAGEMENT028-04587
- reports for this filerHorizon Investments, LLC028-15165
- reports for this filerALTA CAPITAL MANAGEMENT LLC/028-05119
- reports for this filerGOLDMAN SACHS GROUP INC028-04981
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Schwab U.S. Large-Cap ETF | 808524201 | SHS | 32,805 | $841,126 | dollars as filed | |
| ISHARES MSCI USA QUALITY FACTOR ETF | 46432F339 | ETF | 1,942 | $372,457 | dollars as filed | |
| SPY | 78462F103 | SHS | 485 | $315,289 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 13,647 | $298,460 | dollars as filed | |
| Vanguard Growth | 922908736 | COM | 514 | $224,510 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 86,017 | $201,280 | dollars as filed | |
| GAMCO NAT RES GOLD & INCOME | 36465E101 | SH BEN INT | 22,212 | $185,470 | dollars as filed | |
| GAMCO GLOBAL GOLD NAT RES & | 36465A109 | COM SH BEN INT | 26,803 | $142,592 | dollars as filed | |
| MORGAN STANLEY EMERGING MKTS | 617477104 | COM | 23,510 | $119,196 | dollars as filed | |
| TEMPLETON EMERGING MKTS INCO | 880192109 | COM | 18,500 | $111,185 | dollars as filed | |
| FS CREDIT OPPORTUNITIES CORP | 30290Y101 | COMMON STOCK | 21,285 | $108,554 | dollars as filed | |
| SABA CAPITAL INCOME & OPPORT | 880198205 | COM NEW | 12,250 | $101,920 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 10,000 | $12,000 | dollars as filed | |
| QUINCE THERAPEUTICS INC COM | 22053A305 | Stock | 94,201 | $9,552 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002161353-26-000004 | superseded | 2026-11-03 | ||
| 13F-HR/A 0002161353-26-000007 | this filing | 2026-11-04 |